| 中文名称 | 匹格列酮盐酸盐 |
|---|---|
| 中文别名 | 吡格列酮;5-{4-[2-(5-乙基-2-吡啶)-乙氧基]-苯基}-2,4-噻唑烷二酮盐酸盐;盐酸吡格列酮;皮格列酮;匹格列酮盐酸盐;盐酸皮格列酮;盐酸匹格列酮;盐酸吡咯列酮;安可妥;吡格列酮 GMP;Pioglitazone HCl 标准品;吡格列酮苯酸酯杂质;吡格列酮标准品(JP);吡格列酮系统适应性 EP标准品;吡格列酮盐酸盐;低分子右旋糖酐;硒化卡拉胶;盐酸比格列酮;盐酸吡格列酮 EP标准品;盐酸吡格列酮 USP标准品;盐酸吡格列酮 标准品;盐酸吡格列酮中间体;比格列酮;盐酸吡格列酮;吡格列酮烯;盐酸吡格列酮系统适应性 |
| 英文名称 | Pioglitazone hydrochloride |
| 英文别名 | Pioglitazone Hydrochloride;Pioglitazone HCl;Pioglitazone N-Oxide;[5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-] thiazolidinedione hydrochloride;5-(4-(2-(5-Ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione hydrochloride;Pioglitazone Hydroch;5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione monohydrochloride;5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione Hydrochloride;ACTOS;AD 4833;AD-4833;Effects of pioglitazone;Pioditazone hydrochloride;PIODLITAZONE HYDROCHLORIC;pioglitazone hydrochioride;U 72107A;5-[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]benzyl]thiazolidine-2,4-dione hydrochloride;U-72107E;U-72107A;Pioglitazone (hydrochloride);Actos (TN);DSSTox_RID_80116;DSSTox_CID_24203;(+-)-5-(p-(2-(5-Ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione monohydrochloride;DSSTox_GSID_44203;C19H21ClN2O3S;Glustin;DSSTox_GS;Q-201584;DUETACT COMPONENT PIOGLITAZONE HYDROCHLORIDE;Pioglitazone hydrochloride (JP17/USP);Pioglitazone (as hydrochloride);NSC-758876;PIOGLITAZONE HYDROCHLORIDE COMPONENT OF DUETACT;Pioglitazone hydrochloride [USAN:USP];CHEMBL1715;5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione HCl;STR-001;Pioglitazone Hydrochloride ,(S);5-[[4-[2-(5-Ethyl-2-pyridinyl)-etho xy]phenyl]methyl]-2,4-thiazolidinedione hydrochloride;HMS1922L05;Piomed;2,4-THIAZOLIDINEDIONE, 5-((4-(2-(5-ETHYL-2-PYRIDINYL)ETHOXY)PHENYL)METHYL)-, MONOHYDROCHLORIDE, (+/-)-;CHEBI:8229;Pioglitazone hydrochloride, European Pharmacopoeia (EP) Reference Standard;ACTOPLUS MET COMPONENT PIOGLITAZONE HYDROCHLORIDE;AC-1037;2,4-Thiazolidinedione, 5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-, monohydrochloride, (+-)-;5-({4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione hydrochloride;BP164272;Pioglitazone hydrochloride, United States Pharmacopeia (USP) Reference Standard;SPECTRUM1504401;(+/-)-5-(P-(2-(5-ETHYL-2-PYRIDYL)ETHOXY)BENZYL)-2,4-THIAZOLIDINEDIONE MONOHYDROCHLORIDE;Clorhidrato de pioglitazona;5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione hydrochloride;POZE;PIOGLITAZONE HYDROCHLORIDE (USP MONOGRAPH);5-[4-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione hydrochloride;HY-14601;MLS001401386;127676-30-6;DTXSID3044203;BCP22942;KS-1186;P1901;5-[[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione hydrochloride;AKOS015844016;FT-0601607;PIOGLITAZONE HYDROCHLORIDE [MI];UNII-JQT35NPK6C;Q27281642;PIOGLITAZONE HYDROCHLORIDE [USP MONOGRAPH];JQT35NPK6C;PIOGLITAZONE HYDROCHLORIDE [EP MONOGRAPH];AM20061770;PIOGLITAZONE HYDROCHLORIDE [VANDF];PIOGLITAZONE HYDROCHLORIDE [MART.];PIOGLITAZONE HYDROCHLORIDE [USP-RS];D00945;PIOGLITAZONE HYDROCHLORIDE COMPONENT OF OSENI;PIOGLITAZONE HYDROCHLORIDE COMPONENT OF ACTOPLUS MET;PIOGLITAZONE HYDROCHLORIDE [JAN];Pioglitazone for system suitability, European Pharmacopoeia (EP) Reference Standard;Pioglitazo... |
| CAS No. | 112529-15-4 |
| 分子式 | C19H21ClN2O3S |
| 分子量 | 392.90 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学